FDA 510(k)

GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS

K-Number: K870074 · 1987-04-14

ApplicantMicroscan Div. Baxter Healthcare Corp.

Decision Date1987-04-14

Product CodeJWY

Advisory CommitteeMI

DecisionSubstantially Equivalent

Device Summary

GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS is the device name listed in this FDA 510(k) record. The listed applicant is Microscan Div. Baxter Healthcare Corp.. It received FDA 510(k) clearance on 1987-04-14 under 510(k) number K870074. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS?

GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS is a medical device that received FDA 510(k) clearance on 1987-04-14. The listed applicant is Microscan Div. Baxter Healthcare Corp.. The 510(k) number is K870074.

When did GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS receive FDA 510(k) clearance?

GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS received FDA 510(k) clearance on 1987-04-14, under 510(k) number K870074.

Who is the listed applicant for GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS?

The FDA 510(k) record lists Microscan Div. Baxter Healthcare Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS?

The FDA product code for GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS is JWY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Microscan Div. Baxter Healthcare Corp. as applicant

K871232ANTIBODY ASSAY FOR DETECT. OF PARAINFLUENZA TYPE 3 K871229ANTIBODY ASSAY FOR DETECTION OF ADENOVIRUS IN CELL K871233ANTIBODY ASSAY FOR DETECTION OF INFLUENZA A K871228ANTIBODY ASSAY FOR DETECT. OF PARAINFLUENZA TYPE 2 K871231ANTIBODY ASSAY FOR DETECTION OF INFLUENZA B K871234ANTIBODY ASSAY FOR DETECT. OF PARAINFLUENZA TYPE 1

View all 11 devices →

Related Devices (Code: JWY)

K260447ETEST Gepotidacin (GEP) (0.016-256 µg/mL)bioMérieux SA K260696MTS Gepotidacin 0.016-256 µg/mLLiofilchem s.r.l.K252114MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mLLiofilchem s.r.l.K252062The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mLThermo Fisher Scientific K250575The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mLThermo Fisher Scientific K252014The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mLThermo Fisher Scientific

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.